Aug 24, 2026 06:51AM
Aug 11, 2026 09:38AM
Jun 5, 2026 02:13AM
May 12, 2026 08:59AM
Apr 9, 2026 08:01AM
Apr 2, 2026 08:01AM
Mar 18, 2026 08:00AM Coya Therapeutics study shows immune dysfunction in dementia patients
Mar 16, 2026 09:22AM
Feb 2, 2026 06:50AM
Jan 20, 2026 08:04AM
Jan 8, 2026 08:02AM
Jan 5, 2026 08:03AM
Jan 5, 2026 06:42AM
Dec 23, 2025 08:01AM Coya Therapeutics receives Health Canada approval for ALS trial expansion
Dec 11, 2025 06:44AM
Nov 24, 2025 06:41AM
Nov 12, 2025 04:35PM
Nov 4, 2025 08:01AM
Oct 14, 2025 10:55AM
Sep 29, 2025 08:02AM
Sep 23, 2025 06:38AM H.C. Wainwright Reiterates Buy Rating on Coya Therapeutics (COYA)
Sep 22, 2025 09:50AM
Sep 16, 2025 08:01AM
Sep 4, 2025 08:03AM
Aug 25, 2025 06:42AM
Aug 25, 2025 05:22AM
Aug 12, 2025 08:37AM
Aug 12, 2025 08:03AM Coya Therapeutics, Inc. (COYA) Misses Q2 EPS by 49c
Jul 24, 2025 08:15AM
Jul 9, 2025 08:48AM
Jun 9, 2025 06:45AM
Jun 9, 2025 06:05AM
Jun 2, 2025 08:02AM
May 13, 2025 04:08PM
May 13, 2025 08:02AM Coya Therapeutics, Inc. (COYA) Tops Q1 EPS by 2c
Apr 24, 2025 08:15AM
Apr 21, 2025 09:52AM
Apr 17, 2025 07:02AM
Mar 26, 2025 08:15AM
Mar 20, 2025 05:05AM
Feb 6, 2025 12:38PM
Feb 6, 2025 08:00AM Coya Therapeutics (COYA) Reports Statistically Significant Improvement of Inflammatory Blood Markers in Patients with Alzheimer’s Disease Following Monthly Dosing with Low-Dose IL-2, Further Support
Jan 21, 2025 08:15AM
Dec 18, 2024 08:16AM
Dec 4, 2024 07:05AM
Nov 19, 2024 08:15AM
Nov 6, 2024 08:02AM
Nov 1, 2024 08:16AM
Oct 29, 2024 06:32AM Coya Therapeutics (COYA) Reports Positive Results of a Double-Blind Study of Subcutaneous Low-Dose Interleukin-2
Oct 22, 2024 09:02AM

447,987 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All